Tomohisa Tada

5.2k total citations
51 papers, 1.5k citations indexed

About

Tomohisa Tada is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tomohisa Tada has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 38 papers in Cardiology and Cardiovascular Medicine and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tomohisa Tada's work include Coronary Interventions and Diagnostics (34 papers), Acute Myocardial Infarction Research (17 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Tomohisa Tada is often cited by papers focused on Coronary Interventions and Diagnostics (34 papers), Acute Myocardial Infarction Research (17 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Tomohisa Tada collaborates with scholars based in Germany, Japan and Italy. Tomohisa Tada's co-authors include Adnan Kastrati, Salvatore Cassese, Lamin King, Robert A. Byrne, Massimiliano Fusaro, Karl‐Ludwig Laugwitz, Tareq Ibrahim, Michael Joner, Susanne Pinieck and Michael Joner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Tomohisa Tada

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohisa Tada Germany 20 1.1k 1.1k 381 326 91 51 1.5k
Tae‐Hyun Yang South Korea 19 684 0.6× 818 0.8× 465 1.2× 308 0.9× 111 1.2× 73 1.3k
Maurits T. Dirksen Netherlands 17 950 0.8× 1.1k 1.0× 392 1.0× 247 0.8× 67 0.7× 39 1.4k
Jeehoon Kang South Korea 21 726 0.6× 968 0.9× 237 0.6× 138 0.4× 137 1.5× 125 1.5k
Paul Guedeney France 18 701 0.6× 1.1k 1.0× 344 0.9× 201 0.6× 81 0.9× 90 1.6k
Massimo Margheri Italy 21 1.1k 0.9× 1.4k 1.3× 441 1.2× 260 0.8× 236 2.6× 71 1.8k
Makoto Orii Japan 20 839 0.7× 681 0.6× 643 1.7× 357 1.1× 48 0.5× 77 1.3k
Klaus Tiroch Germany 21 1.4k 1.2× 1.3k 1.2× 747 2.0× 466 1.4× 107 1.2× 48 2.0k
Keyur Parikh India 16 777 0.7× 1.3k 1.2× 285 0.7× 557 1.7× 224 2.5× 42 1.7k
Quanmin Jing China 18 782 0.7× 1.0k 0.9× 182 0.5× 206 0.6× 184 2.0× 105 1.3k
Raisuke Iijima Japan 27 1.6k 1.5× 1.9k 1.8× 761 2.0× 567 1.7× 275 3.0× 101 2.6k

Countries citing papers authored by Tomohisa Tada

Since Specialization
Citations

This map shows the geographic impact of Tomohisa Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Tada more than expected).

Fields of papers citing papers by Tomohisa Tada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Tada. The network helps show where Tomohisa Tada may publish in the future.

Co-authorship network of co-authors of Tomohisa Tada

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Tada. A scholar is included among the top collaborators of Tomohisa Tada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Tada. Tomohisa Tada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimojo, Takashi, Naoaki Onishi, Yohei Kobayashi, et al.. (2025). Conservative Management for Left Atrial Intramural Hematoma After Cryoballoon Ablation. JACC Case Reports. 31(6). 106328–106328.
2.
Takahashi, Kotaro, et al.. (2023). A snare maneuver to reposition self-expandable aortic valve after transcatheter replacement of surgically implanted valve. Journal of Cardiology Cases. 28(6). 269–270.
3.
Nishikawa, Ryusuke, Hiroki Shiomi, Takeshi Morimoto, et al.. (2023). Effects of peripheral artery disease on long-term outcomes after percutaneous coronary intervention versus coronary artery bypass grafting in patients with severe coronary artery disease. Journal of Cardiology. 84(4). 279–286. 2 indexed citations
4.
Yamamoto, Ko, Takeshi Morimoto, Masahiro Natsuaki, et al.. (2023). Statin Discontinuation After Coronary Revascularization. The American Journal of Cardiology. 207. 479–489. 2 indexed citations
5.
Fuku, Yasushi, Kazushige Kadota, Mamoru Toyofuku, et al.. (2019). Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions. The American Journal of Cardiology. 123(11). 1796–1805. 13 indexed citations
6.
Joner, Michael, Tobias Koppara, Robert A. Byrne, et al.. (2018). Neoatherosclerosis in Patients With Coronary Stent Thrombosis. JACC: Cardiovascular Interventions. 11(14). 1340–1350. 34 indexed citations
7.
Tanaka, Nobuhiro, Hiroyuki Okura, Kiyoshi Yoshida, et al.. (2015). Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation. Cardiovascular Intervention and Therapeutics. 31(1). 29–37. 17 indexed citations
8.
Ndrepepa, Gjin, Siegmund Braun, Tomohisa Tada, et al.. (2014). Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Cardiovascular revascularization medicine. 15(3). 131–136. 15 indexed citations
9.
Tada, Tomohisa, Adnan Kastrati, Robert A. Byrne, et al.. (2014). Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography. International journal of cardiac imaging. 30(3). 495–504. 24 indexed citations
10.
Tada, Tomohisa, Robert A. Byrne, Iva Šimunović, et al.. (2013). Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents. JACC: Cardiovascular Interventions. 6(12). 1267–1274. 234 indexed citations
11.
Fusaro, Massimiliano, Salvatore Cassese, Gjin Ndrepepa, et al.. (2013). Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: A meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. International Journal of Cardiology. 168(4). 4002–4009. 32 indexed citations
12.
Ndrepepa, Gjin, S. Schulz, Franz‐Josef Neumann, et al.. (2013). Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. American Heart Journal. 166(3). 534–540. 31 indexed citations
13.
Tada, Tomohisa, Robert A. Byrne, Tibor Schuster, et al.. (2013). Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. Cardiovascular revascularization medicine. 14(2). 84–89. 16 indexed citations
14.
Bao, Bingyuan, Neiko Ozasa, Takeshi Morimoto, et al.. (2012). β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction. Cardiovascular Intervention and Therapeutics. 28(2). 139–147. 24 indexed citations
15.
Ndrepepa, Gjin, Tomohisa Tada, Massimiliano Fusaro, et al.. (2012). Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clinical Research in Cardiology. 101(12). 1003–1011. 36 indexed citations
16.
Waha, Antoinette de, Salvatore Cassese, Duk‐Woo Park, et al.. (2012). Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clinical Research in Cardiology. 101(6). 461–467. 38 indexed citations
17.
Ndrepepa, Gjin, Lamin King, Salvatore Cassese, et al.. (2012). Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention. European Journal of Internal Medicine. 24(2). 145–150. 4 indexed citations
18.
Kimura, Takeshi, Takeshi Morimoto, Yoshihisa Nakagawa, et al.. (2012). Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovascular Intervention and Therapeutics. 27(3). 181–188. 7 indexed citations
19.
Tada, Tomohisa, Robert A. Byrne, Salvatore Cassese, et al.. (2012). Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease. American Heart Journal. 165(1). 80–86. 28 indexed citations
20.
Tada, Tomohisa, Masatoshi Fujita, Tomoyuki Gotō, et al.. (2009). A case with sudden onset of position-dependent hypoxemia caused by reopening of foramen ovale. Journal of Cardiology Cases. 1(2). e88–e91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026